Xenon Pharmaceuticals Inc.

Organization

Burnaby, CA

Ticker Symbols

NASDAQ:XENE

PHARMACEUTICAL PREPARATIONS
Business Address
200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Mailing Address
200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
State Location
A1
State of Incorporation
A1

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating depressive disorders
- Patent number 12,178,811
- Issue date Dec 31, 2024
- Xenon Pharmaceuticals Inc.
- Cynthia Louise Harden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and uses for treating anhedonia
- Patent number 12,171,759
- Issue date Dec 24, 2024
- Xenon Pharmaceuticals Inc.
- Simon Neil Pimstone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyridine derivatives and their use as sodium channel activators
- Patent number 12,054,486
- Issue date Aug 6, 2024
- Xenon Pharmaceuticals Inc.
- Verner Alexander Lofstrand
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and uses for treating anhedonia
- Patent number 11,957,675
- Issue date Apr 16, 2024
- Xenon Pharmaceuticals Inc.
- Simon Neil Pimstone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl-substituted sulfonamide compounds and their use as thera...
- Patent number 11,639,351
- Issue date May 2, 2023
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 11,325,902
- Issue date May 10, 2022
- Xenon Pharmaceuticals Inc.
- Kristen Nicole Burford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 11,299,490
- Issue date Apr 12, 2022
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides and methods of use thereof
- Patent number 11,203,572
- Issue date Dec 21, 2021
- Genentech, Inc.
- Sultan Chowdhury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzenesulfonamide compouds and their use as therapeutic agents
- Patent number 11,174,268
- Issue date Nov 16, 2021
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 11,149,002
- Issue date Oct 19, 2021
- Genentech, Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for enhancing the bio availability and exposure of a voltag...
- Patent number 11,135,214
- Issue date Oct 5, 2021
- Xenon Pharmaceuticals Inc.
- Gregory N. Beatch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 11,130,726
- Issue date Sep 28, 2021
- Genentech, Inc.
- Ivan William Hemeon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid state crystalline forms of a selective potassium channel modu...
- Patent number 11,091,441
- Issue date Aug 17, 2021
- Xenon Pharmaceuticals Inc.
- Paul Robert Bichler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl-substituted sulfonamide compounds and their use as thera...
- Patent number 10,981,905
- Issue date Apr 20, 2021
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides useful as sodium channel blockers
- Patent number 10,899,732
- Issue date Jan 26, 2021
- Genentech, Inc.
- Chien-an Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 10,815,229
- Issue date Oct 27, 2020
- Xenon Pharmaceuticals Inc.
- Kristen Nicole Burford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 10,787,446
- Issue date Sep 29, 2020
- Genentech, Inc.
- Philippe Bergeron
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted benzamides and methods of use thereof
- Patent number 10,766,858
- Issue date Sep 8, 2020
- Genentech, Inc.
- Sultan Chowdhury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl-substituted sulfonamide compounds and their use as sodiu...
- Patent number 10,752,623
- Issue date Aug 25, 2020
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 10,745,392
- Issue date Aug 18, 2020
- Xenon Pharmaceuticals Inc.
- Kristen Nicole Burford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 10,662,184
- Issue date May 26, 2020
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 10,526,285
- Issue date Jan 7, 2020
- Genentech, Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid state forms of spiro-oxindole compounds
- Patent number 10,513,526
- Issue date Dec 24, 2019
- Xenon Pharmaceuticals Inc.
- Ronen Ben-David
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 10,457,654
- Issue date Oct 29, 2019
- Genentech, Inc.
- Daniel Sutherlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzenesulfonamide compounds and their use as therapeutic agents
- Patent number 10,246,453
- Issue date Apr 2, 2019
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzamides and methods of use thereof
- Patent number 10,179,767
- Issue date Jan 15, 2019
- Genentech, Inc.
- Sultan Chowdhury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds and methods of use thereof
- Patent number 10,125,098
- Issue date Nov 13, 2018
- Genentech, Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid state forms of spiro-oxindole compounds
- Patent number 10,118,932
- Issue date Nov 6, 2018
- Xenon Pharmaceuticals Inc.
- Ronen Ben-David
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Asymmetric synthesis of funapide
- Patent number 10,100,060
- Issue date Oct 16, 2018
- Xenon Pharmaceuticals Inc.
- Ronen Ben-David
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted benzamides and methods of use thereof
- Patent number 10,071,957
- Issue date Sep 11, 2018
- Genentech, Inc.
- Christoph Martin Dehnhardt
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CONJOINT THERAPY FOR TREATING SEIZURE DISORDERS
- Publication number 20240408075
- Publication date Dec 12, 2024
- Xenon Pharmaceuticals Inc.
- James Philip JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND USES FOR TREATING ANHEDONIA
- Publication number 20240408076
- Publication date Dec 12, 2024
- Xenon Pharmaceuticals Inc.
- Simon Neil PIMSTONE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING PAIN
- Publication number 20240342156
- Publication date Oct 17, 2024
- Xenon Pharmaceuticals Inc.
- James Philip JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...
- Publication number 20240316033
- Publication date Sep 26, 2024
- Xenon Pharmaceuticals Inc.
- Gregory N. Beatch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...
- Publication number 20240316032
- Publication date Sep 26, 2024
- Xenon Pharmaceutical Inc.
- Gregory N. Beatch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODU...
- Publication number 20240279182
- Publication date Aug 22, 2024
- Xenon Pharmaceuticals Inc.
- Paul Robert BICHLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
- Publication number 20240101531
- Publication date Mar 28, 2024
- Xenon Pharmaceuticals Inc.
- Paul Scott Charifson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF THE NAV1.6 SODIUM CHANNEL BLOCKER (S)-4-((1-BENZYLPYRROLIDIN...
- Publication number 20230405023
- Publication date Dec 21, 2023
- Xenon Pharmaceuticals Inc.
- Gregory N. Beatch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH V...
- Publication number 20230404913
- Publication date Dec 21, 2023
- Xenon Pharmaceuticals, Inc.
- Jean-Jacques Alexandre Cadieux
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
- Publication number 20230203007
- Publication date Jun 29, 2023
- Xenon Pharmaceuticals Inc.
- Verner Alexander Lofstrand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
- Publication number 20230150972
- Publication date May 18, 2023
- Xenon Pharmaceuticals Inc.
- Verner Alexander Lofstrand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS
- Publication number 20230144095
- Publication date May 11, 2023
- Xenon Pharmaceuticals Inc.
- Verner Alexander Lofstrand
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERA...
- Publication number 20220348570
- Publication date Nov 3, 2022
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONJOINT THERAPY FOR TREATING SEIZURE DISORDERS
- Publication number 20220288057
- Publication date Sep 15, 2022
- Xenon Pharmaceuticals Inc.
- James Philip JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND USES FOR TREATING ANHEDONIA
- Publication number 20220265634
- Publication date Aug 25, 2022
- Xenon Pharmaceuticals Inc.
- Simon Neil PIMSTONE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING ABSENCE SEIZURES
- Publication number 20220193070
- Publication date Jun 23, 2022
- Xenon Pharmaceuticals Inc.
- Robin Paul SHERRINGTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...
- Publication number 20220062266
- Publication date Mar 3, 2022
- Xenon Pharmaceuticals Inc.
- Gregory N. Beatch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR
- Publication number 20220064120
- Publication date Mar 3, 2022
- Xenon Pharmaceuticals Inc.
- Paul Robert BICHLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20220055977
- Publication date Feb 24, 2022
- Genentech, Inc.
- Ivan William HEMEON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
- Publication number 20210253548
- Publication date Aug 19, 2021
- Genentech, Inc.
- Chien-an CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING PAIN
- Publication number 20210213009
- Publication date Jul 15, 2021
- Xenon Pharmaceuticals Inc.
- James Philip JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OP...
- Publication number 20210169839
- Publication date Jun 10, 2021
- Xenon Pharmaceuticals Inc.
- Jean-Jacques Alexandre Cadieux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Publication number 20210171537
- Publication date Jun 10, 2021
- Xenon Pharmaceuticals Inc.
- Jean-Christophe Andrez
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20210171516
- Publication date Jun 10, 2021
- Genentech, Inc.
- Philippe BERGERON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING DEPRESSIVE DISORDERS
- Publication number 20210161886
- Publication date Jun 3, 2021
- Xenon Pharmaceuticals Inc.
- Cynthia Louise HARDEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
- Publication number 20210155588
- Publication date May 27, 2021
- Genentech, Inc.
- Sultan CHOWDHURY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODU...
- Publication number 20210147363
- Publication date May 20, 2021
- Xenon Pharmaceuticals Inc.
- Paul Robert BICHLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
- Publication number 20210093618
- Publication date Apr 1, 2021
- Genentech, Inc.
- Jean-Christophe ANDREZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20210078947
- Publication date Mar 18, 2021
- Genentech, Inc.
- Jean-Christophe ANDREZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- Publication number 20200361927
- Publication date Nov 19, 2020
- Xenon Pharmaceuticals Inc.
- Kristen Nicole Burford
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
98855663 - ASM+
- Serial number 98855663
- Filing date Nov 15, 2024
- XENON PHARMACEUTICALS INC.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
98560942
- Serial number 98560942
- Filing date May 21, 2024
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98560961 - XENON
- Serial number 98560961
- Filing date May 21, 2024
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98535548 - EPKEYO
- Serial number 98535548
- Filing date May 6, 2024
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98535543 - DOVRAYA
- Serial number 98535543
- Filing date May 6, 2024
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97700199 - KAYEPI
- Serial number 97700199
- Filing date Dec 1, 2022
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97700206 - KAYSEPO
- Serial number 97700206
- Filing date Dec 1, 2022
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90324839 - EPKEYO
- Serial number 90324839
- Filing date Nov 17, 2020
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90324844 - DOVRAYA
- Serial number 90324844
- Filing date Nov 17, 2020
- XENON PHARMACEUTICALS INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76142636 - EXTREME GENETICS
- Serial number 76142636
- Registration number 2927105
- Filing date Oct 6, 2000
- XENON GENETICS INC.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76142638 - XENON
- Serial number 76142638
- Registration number 2875935
- Filing date Oct 6, 2000
- XENON GENETICS INC.
- 42 - Scientific and technological services and research and design relating thereto

Xenon Pharmaceuticals Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Methods of treating depressive disorders

Methods and uses for treating anhedonia

Pyridine derivatives and their use as sodium channel activators

Methods and uses for treating anhedonia

Heteroaryl-substituted sulfonamide compounds and their use as thera...

Benzenesulfonamide compounds and their use as therapeutic agents

Benzenesulfonamide compounds and their use as therapeutic agents

Substituted benzamides and methods of use thereof

Benzenesulfonamide compouds and their use as therapeutic agents

Therapeutic compounds and methods of use thereof

Methods for enhancing the bio availability and exposure of a voltag...

Therapeutic compounds and methods of use thereof

Solid state crystalline forms of a selective potassium channel modu...

Heteroaryl-substituted sulfonamide compounds and their use as thera...

Substituted benzamides useful as sodium channel blockers

Benzenesulfonamide compounds and their use as therapeutic agents

Therapeutic compounds and methods of use thereof

Substituted benzamides and methods of use thereof

Heteroaryl-substituted sulfonamide compounds and their use as sodiu...

Benzenesulfonamide compounds and their use as therapeutic agents

Benzenesulfonamide compounds and their use as therapeutic agents

Therapeutic compounds and methods of use thereof

Solid state forms of spiro-oxindole compounds

Therapeutic compounds and methods of use thereof

Benzenesulfonamide compounds and their use as therapeutic agents

Substituted benzamides and methods of use thereof

Therapeutic compounds and methods of use thereof

Solid state forms of spiro-oxindole compounds

Asymmetric synthesis of funapide

N-substituted benzamides and methods of use thereof

Patents Applicationslast 30 patents

CONJOINT THERAPY FOR TREATING SEIZURE DISORDERS

METHODS AND USES FOR TREATING ANHEDONIA

METHODS FOR TREATING PAIN

METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...

METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...

SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODU...

PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS

USE OF THE NAV1.6 SODIUM CHANNEL BLOCKER (S)-4-((1-BENZYLPYRROLIDIN...

PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES ASSOCIATED WITH V...

PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS

HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERA...

CONJOINT THERAPY FOR TREATING SEIZURE DISORDERS

METHODS AND USES FOR TREATING ANHEDONIA

METHODS FOR TREATING ABSENCE SEIZURES

METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE...

SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

METHODS OF TREATING PAIN

PEDIATRIC IMMEDIATE-RELEASE FORMULATION OF THE POTASSIUM CHANNEL OP...

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

METHODS OF TREATING DEPRESSIVE DISORDERS

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

SOLID STATE CRYSTALLINE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODU...

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Trademarklast 30 trademarks

98855663 - ASM+

98560942

98560961 - XENON

98535548 - EPKEYO

98535543 - DOVRAYA

97700199 - KAYEPI

97700206 - KAYSEPO

90324839 - EPKEYO

90324844 - DOVRAYA

76142636 - EXTREME GENETICS